• Artivion swung to a third-quarter 2026 net loss of $7.9 million from a year-earlier profit.
• Revenue rose 9% year over year to $123.8 million.
• Preparations for the January 2027 US commercial launch of NEXUS are progressing, with the first surgeon training event planned for December.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artivion Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CL90457) on November 05, 2026, and is solely responsible for the information contained therein.